CCR4 is expressed on infiltrating cells in lesional skin of early mycosis fungoides and atopic dermatitis

Journal of Dermatology

Volumn 42, Issue 6, 2015, Pages 613-615

  Sugaya, Makoto ^a   Morimura, Sohshi ^a   Suga, Hiraku ^a   Kawaguchi, Makiko ^a   Miyagaki, Tomomitsu ^a   Ohmatsu, Hanako ^a   Fujita, Hideki ^a   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

atopic dermatitis; CCR4; mycosis fungoides; psoriasis; S zary syndrome

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; LACTATE DEHYDROGENASE; SOLUBLE INTERLEUKIN 2 RECEPTOR; THYMUS AND ACTIVATION REGULATED CHEMOKINE; CCR4 PROTEIN, HUMAN; DIAGNOSTIC KIT;

ABC STAINING KIT; ARTICLE; ATOPIC DERMATITIS; CCR4 STAINING KIT; CELL INFILTRATION; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE MARKER; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY TEST KIT; INTERMETHOD COMPARISON; LACTATE DEHYDROGENASE BLOOD LEVEL; MYCOSIS FUNGOIDES; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS; SEZARY SYNDROME; TUMOR GROWTH; BLOOD; CHEMISTRY; DIAGNOSTIC KIT; DISEASE COURSE; METABOLISM; SKIN;

DERMATITIS, ATOPIC; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MYCOSIS FUNGOIDES; PSORIASIS; REAGENT KITS, DIAGNOSTIC; RECEPTORS, CCR4; SEZARY SYNDROME; SKIN;

EID: 84930475849     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12852     Document Type: Article

References (10)

1. Saeki H, Tamaki K,. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 2006; 43: 75-84.
2. Kakinuma T, Sugaya M, Nakamura K, et al,. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003; 48: 23-30.
3. Sugaya M,. Chemokines and cutaneous lymphoma. J Dermatol Sci 2010; 59: 81-89.
4. Kallinich T, Muche JM, Qin S, et al,. Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 2003; 121: 1045-1052.
5. Yamaguchi T, Ohshima K, Karube K, et al,. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders. Br J Dermatol 2006; 154: 904-909.
6. Yoshie O, Fujisawa R, Nakayama T, et al,. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002; 99: 1505-1511.
7. Ishii T, Ishida T, Utsunomiya A, et al,. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphoma. Clin Cancer Res 2010; 16: 1520-1531.
8. Sokolowska-Wojdylo M, Wenzel J, Gaffal E, et al,. Circulating clonal CLA(+) and CD4(+) T cells in Sézary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol 2005; 152: 258-264.
9. Morimura S, Sugaya M, Suga H, et al,. TOX expression in different subtypes of cutaneous lymphoma. Arch Dermatol Res 2014; 306: 843-849.
10. Guttman-Yassky E, Nograles KE, Krueger JG,. Contrasting pathogenesis of atopic dermatitis and psoriasis-part II: immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011; 127: 1420-1432.